While, targeting HIF1 and other associated potential biomarkers may in fact reduce mortality associated with breast cancer in diabetic patients, eventually alleviating the socioeconomic burden of diabetes- breast cancer association on global health. Here, HIF1A is linked to diabetes mellitus.